Asymmetric Reduction and KR Using W110A TESADH
Biocatalytic processes also are less hazardous and energy
consuming than conventional chemistry methodologies. They
are normally carried out under mild conditions, which minimize
problems of product isomerization, racemization, or epimeriza-
tion. Biocatalysts are easily produced at low cost and with
minimum waste, and they can be decomposed in the environ-
ment after use. Unfortunately, they do have some disadvantages.
For example, many enzymes are thermally unstable. Another
disadvantage is the limited solubility of most organic substrates
in water; this leads to larger reaction volumes, a need for
cosolvents, and complicated product recovery.6
FIGURE 1. Prelog’s rule for predicting the stereochemistry of alcohols
formed from their corresponding ketones by asymmetric reduction with
ADHs.
Alcohol dehydrogenases (ADHs, EC 1.1.1.X, X ) 1 or 2)
are enzymes that catalyze the reversible reduction of ketones
and aldehydes to the corresponding alcohols. The asymmetric
reduction of ketones using the commercially available yeast
ADH and horse liver ADH is limited not only due to their
temperature sensitivity, but also due to their sensitivity toward
organic solvents and their loss of activity upon immobilization.
An additional disadvantage of horse liver ADH is its low affinity
for acyclic ketones.1b,7 Secondary ADH from Thermoanaero-
bacter ethanolicus (TESADH, EC 1.1.1.2), a highly thermo-
stable enzyme, has been isolated and characterized.8 NADPH
is required by this enzyme, from which the hydride is transferred
to the carbonyl carbon. Because NADPH is a costly cofactor,
alcohols like 2-propanol or ketones like acetone are used as
hydrogen source or hydrogen sink to regenerate the cofactor
and therefore make both processes catalytic. This enzyme is
stable at temperatures up to 80 °C, and it exhibits high activity
in the asymmetric reduction of ketones.9 Because of its
thermostability, resistance to organic solvents, and reactivity
for a wide variety of substrates, it is a useful biocatalyst for
synthetic applications.10
propargyl alcohols using wild-type TESADH.10a The behavior
of TESADH has been shown to be similar to results obtained
from reductions with a very highly homologous (99% identity),8b
NADPH-dependent,ThermoanaerobiumbrockiiADH(TBADH).11
For TBADH, Keinan et al. suggested that the two alkyl groups
of substrates occupy two hydrophobic sites, which differ from
one another in volume and also in their affinities toward the
alkyl groups (Figure 1).11 It was also shown that the small site,
which has higher affinity toward the alkyl groups of the ketone,
can accommodate up to three carbon substituents, like the
isopropyl group.10a,b,11
We have recently reported a new mutant of TESADH, where
tryptophan-110 was substituted by alanine (W110A TE-
SADH).12 This replacement makes the large pocket able to
accommodate phenyl ring-containing substrates that are not
substrates for wild-type TESADH.10b Its modified substrate
range makes this mutant enzyme useful for the enantioselective
reduction of phenyl ring-containing ketones such as 4-phenyl-
2-butanone (1a) and, in the reverse direction, for the enanti-
oselective oxidation via KR of racemic phenyl ring-containing
secondary alcohols.
A series of ethynyl ketones and ethynylketoesters were
reduced enantioselectively to the corresponding nonracemic
(3) (a) Zhu, D.; Yang, Y.; Hua, L. J. Org. Chem. 2006, 71, 4202-4205.
(b) Stampfer, W.; Kosjek, B.; Faber, K.; Kroutil, W. J. Org. Chem. 2003,
68, 402-406. (c) Yadav, J. S.; Nanda, S.; Reddy, P. T.; Rao, A. B. J. Org.
Chem. 2002, 67, 3900-3903. (d) Schubert, T.; Hummel, W.; Mu¨ller, M.
Angew. Chem., Int. Ed. 2002, 41, 634-636. (e) Stampher, W.; Kosjek, B.;
Moitzi, C.; Kroutil, W.; Faber, K. Angew. Chem., Int. Ed. 2002, 41, 1014-
1017. (f) Nakamura, K.; Inoue, Y.; Matsuda, T.; Misawa, I. J. Chem. Soc.,
Perkin Trans. 1 2000, 2397-2402. (g) Bortolini, O.; Fantin, G.; Fogagnolo,
M.; Giovannini, P. P.; Guerrini, A.; Medici, A. J. Org. Chem. 1997, 62,
1854-1856. (h) Grunwald, J.; Wirz, B.; Scollar, M. P.; Kilbanov, A. M.
J. Am. Chem. Soc. 1986, 108, 6732-6734.
(4) (a) Birman, V. B.; Jiang, H. Org. Lett. 2005, 7, 3445-3447. (b)
Ghanem, A.; Aboulenein, H. Y. Chirality 2005, 17, 1-15. (c) Martin-
Matute, B.; Edin, M.; Bogar, K.; Bachva¨ll, J. E. Angew. Chem., Int. Ed.
2004, 43, 6535-6539. (d) Birman, V. B.; Uffman, E. W.; Jiang, H.; Li,
X.; Kilbane, C. J. J. Am. Chem. Soc. 2004, 126, 12226-12227. (e)
Nakamura, K.; Matsuda, T.; Harada, T. Chirality 2002, 14, 703-708. (f)
Kim, K.; Song, B.; Choi, M.; Kim, M. Org. Lett. 2001, 3, 1507-1509.
(5) (a) Weinert, C. S.; Fanwick, P. E.; Rothwell, I. P. Organometallics
2005, 24, 5759-5766. (b) Noyori, R.; Okhuma, T. Angew. Chem., Int. Ed.
2001, 40, 40-73. (c) Blake, A. J.; Cunningham, A.; Ford, A.; Teat, S. J.;
Woodward, S. Chem.-Eur. J. 2000, 6, 3586-3594.
(6) (a) Gervais, T. R.; Carta, G.; Gianer, J. L. Biotechnol. Prog. 2003,
49, 389-395. (b) Cao, L.; Langen, L. V.; Sheldon, R. A. Curr. Opin.
Biotechnol. 2003, 14, 387-394. (c) Kilbanov, A. M. Nature 2001, 409,
241-246. (d) Koeller, M. K.; Wong, C. H. Nature 2001, 409, 232-240.
(e) Riva, S.; Carrea, G. Angew. Chem., Int. Ed. 2000, 39, 2226-2254.
(7) (a) Kovalenko, G. A.; Sokolovskii, V. D. Biotechnol. Bioeng. 1983,
25, 3177-3184. (b) Pollak, A.; Blumenfeld, H.; Wax, M.; Baughn, R. L.;
Whitesides, G. M. J. Am. Chem. Soc. 1980, 102, 6324-6336.
(8) (a) Burdette, D.; Zeikus, J. G. Biochem. J. 1994, 302, 163-170. (b)
Burdette, D. S.; Vieille, C.; Zeikus, J. G. Biochem. J. 1996, 316, 115-122.
(9) (a) Pham, V. T.; Phillips, R. S. J. Am. Chem. Soc. 1990, 112, 3629-
3632. (b) Pham, V. T.; Phillips, R. S.; Ljugdahl, L. G. J. Am. Chem. Soc.
1989, 111, 1935-1936.
Results and Discussion
A series of phenyl ring-containing ketones, which could not
be reduced by wild-type TESADH, were reduced by W110A
TESADH to produce the corresponding nonracemic alcohols
with good yields and high optical purities (Table 1). The
reductions were carried out in Tris buffer containing 30% (v/v)
2-propanol, which serves as both cosolvent and hydride source
to reduce the oxidized coenzyme. The use of such a high
percentage of 2-propanol was crucial not only to enhance the
solubility of the hydrophobic phenyl ring-containing ketone
substrates in aqueous media, but also to shift the equilibrium
into the reduction direction. The produced alcohols had S
configuration, in agreement with Prelog’s rule, in which the
NADPH cofactor transfers its pro-R hydride to the re face of
the ketone (Figure 1).1b,c,13
Phenyl ring-containing 2-butanone derivatives were reduced
to the corresponding (S)-alcohols with excellent stereoselec-
(10) (a) Heiss, C.; Phillips, R. S. J. Chem. Soc., Perkin Trans. 1 2000,
2821-2825. (b) Heiss, C.; Laivenieks, M.; Zeikus, J. G.; Phillips, R. S.
Bioorg. Med. Chem. 2001, 9, 1659-1666. (c) Heiss, C.; Laivenieks, M.;
Zeikus, G.; Phillips, R. S. J. Am. Chem. Soc. 2001, 123, 345-346. (d) Tripp,
A. E.; Burdette, D. S.; Zeikus, J. G.; Phillips, R. S. J. Am. Chem. Soc.
1998, 120, 5137-5141.
(11) Keinan, E.; Hafeli, E. K.; Seth, K. K.; Lamed, R. J. Am. Chem.
Soc. 1986, 108, 162-169.
(12) Ziegelmann-Fjeld, K. I.; Musa, M. M.; Phillips, R. S.; Zeikus,
J. G.; Vieille, C. Protein Eng. Des., in press.
(13) Prelog, V. Pure Appl. Chem. 1964, 9, 119-130.
J. Org. Chem, Vol. 72, No. 1, 2007 31